Similar articles

• Immunologic and nonimmunologic risk factors of chronic rejection.

  Fellström B, Backman U, Larsson E, Zezina L. Fellström B, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1304-5. doi: 10.1016/s0041-1345(98)02007-7. Transplant Proc. 1999. PMID: 10083582 Review. No abstract available.
• Specific inhibition of heart allograft rejection by serum from liver-grafted rats.

  Kamada N, Shinomiya T, Tamaki T. Kamada N, et al. Transplant Proc. 1987 Feb;19(1 Pt 1):570-1. Transplant Proc. 1987. PMID: 3274823 No abstract available.
• Indirect T-cell recognition in human allograft rejection.

  Suciu-Foca N, Liu Z, Colovai AI, Fisher P, Ho E, Reed EF, Rose EA, Michler RE, Hardy MA, Cocciolo P, Gargano F, Cortesini R. Suciu-Foca N, et al. Transplant Proc. 1997 Feb-Mar;29(1-2 /01):1012-3. doi: 10.1016/s0041-1345(96)00347-8. Transplant Proc. 1997. PMID: 9123174 No abstract available.
• Late xenograft rejection: comparison between liver and heart xenografts under low-dose tacrolimus.

  Molleví DG, Morell Ginestà M, Ribas Y, Mestre M, Vidal A, Serano T, Figueras J, Jaurrieta J. Molleví DG, et al. Transplant Proc. 2002 Feb;34(1):111-2. doi: 10.1016/s0041-1345(01)02693-8. Transplant Proc. 2002. PMID: 11959212 No abstract available.
• The role of transforming growth factor-beta in transplant rejection.

  Hutchinson IV. Hutchinson IV. Transplant Proc. 1999 Nov;31(7A):9S-13S. doi: 10.1016/s0041-1345(99)00785-x. Transplant Proc. 1999. PMID: 10576034 Review. No abstract available.